Targeted alpha therapy using astatine (²¹¹At)-labeled phenylalanine: A preclinical study in glioma bearing mice.

Although there was no significant difference in the in vitro cellular uptake and the residence time of meta- 211 At-PA and para- 211 At-PA in normal organs, BCH treatment showed a small trend towards greater inhibition (% inhibition compared to the control) of para- 211 At-PA uptake compared to meta- 211 At-PA in all cell-lines ( Figure 2 ).

also in 722 other papers